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Abstract
A 65-year-old female was transferred with myocardial infarction, three-vessel
coronary artery disease, cardiogenic shock and an intraaortic balloon pump. Given
persistent shock, mechanical circulatory support (MCS) was upgraded using a left
ventricular hemodynamic support device (Impella CP). The patient was monitored in
the catheterization laboratory and serial hemodynamic measures were obtained. Initial hemodynamics showed relative improvement; however, serial assessments demonstrated worsening hemodynamics secondary to right ventricular failure, ultimately
requiring a right ventricular hemodynamic support device. The case highlights the
rapid changes that can occur with mechanical circulatory support devices and demonstrates the importance of obtaining serial hemodynamics in the cardiac catheterization laboratory.
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Electrocardiogram revealed anterior q-waves and ST depression in the
inferior leads. Her initial laboratory revealed a mildly elevated tropo-

Acute myocardial infarction complicated by cardiogenic shock

nin, normal serum creatinine, and mild transaminitis. Echocardiogram

(AMI-CS) is associated with significant morbidity and mortality. When

demonstrated depressed LV ejection fraction approximately 15%, nor-

left ventricular (LV) dysfunction is associated with right ventricular

mal RV size, moderately reduced global RV function, and severe mitral

(RV) dysfunction, morbidity and mortality are even higher. Routine

regurgitation (Videos S4–S7). The patient was treated as a non-ST ele-

assessment of hemodynamics with the use of a pulmonary artery

vation myocardial infarction with intravenous heparin infusion. Shortly

catheter (PAC) remains infrequently performed. PACs allows for early

after transfer to the medical floor, the patient became hypoxic devel-

hemodynamic assessment in patients treated with mechanical circula-

oping flash pulmonary edema and requiring emergent intubation.

tory support (MCS). In the following case we highlight the importance

Emergent coronary angiography was performed due to suspected car-

of serial hemodynamic measures when using MCS and why serial

diogenic shock and revealed three-vessel coronary artery disease

assessments performed in the cardiac catheterization laboratory can

(Figure 1, Videos S1–S3), for which an intraaortic balloon pump (IABP)

be helpful. The case demonstrates the early detection of RV failure

was placed. The patient was transferred to our hospital for escalation

1

after placement placement of a LV MCS device.

of care. On arrival, the patient was hypotensive (80/41 mmHg) and
tachycardic (104 bpm) with SCAI stage D shock refractory to IABP
and inotropes (norepinephrine and dobutamine). Her laboratory
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results revealed

a

high-sensitivity

troponin

of

greater

than

20,000 ng/L (Normal <19 ng/L), lactic acid of 3.6 mg/dL, oliguria with
A 65-year-old female with a history of hypertension presented with

a rising serum creatinine, and elevated liver function tests concerning

2 days of worsening chest pain and fatigue to an outside hospital.

for multiorgan failure. The patient was urgently taken to the cardiac
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FIGURE 1
TABLE 1

Coronary angiograms showing three-vessel coronary artery disease

Trend of hemodynamics

Parameter

Prior mechanical circulatory
support (MCS)

Immediately post-left
sided MCS

45 min post-left
sided MCS

HR (bpm)

104

149

140

121

92

Blood pressure
(mmHg) [MAP]

80/41 (61)

115/84 (94)

73/53 (60)

77/ 70 (72)

94/71 (78)

RA (mmHg)

15

12

15

10

7

PA (mmHg)

34/26 (30)

24/16 (20)

23/19 (20)

27/19 (22)

25/14 (18)

PCWP (mmHg)

26

16

-

-

-

PA sat (%)

55

59

38

62

71

CO (L/min)

3.38

4.18

3.1

3.7

5.7

CI (L/min/m )

1.94

2.4

1.7

2.1

3.3

CPO (W)

0.52

0.9

0.4

0.59

0.99

PAPI

0.73

0.8

0.27

0.8

1.6

RVSWI

281

161

61

209

395

Inotropes

Dobutamine 5 mcg/kg/hr and norepinephrine 3–5 mcg/min

2

catheterization laboratory, where a PAC was placed revealing a car2

24 hr postbiventricular MCS

48 hr postbiventricular MCS

the patient's hospital course was complicated by ventilator-associated

diac index (CI) of 1.94 L/min/m , a cardiac power output (CPO) of

pneumonia and sepsis. She completed her antibiotic course, her kid-

0.52 W and a pulmonary pulsatility index (PAPI) of 0.73. Given the

ney function improved, her mental status remained intact and she was

patient's deteriorating condition the decision was made to upgrade

discharged on guideline-directed medical therapy to a rehabilitation

MCS to an Impella CP. Immediate hemodynamic assessment was

facility. She was subsequently discharged home and has done well

promising (Table 1). However, as we continued to monitor the patient

with 12 months of follow up.

in the catheterization laboratory and performed serial hemodynamic
assessments, hemodyanamic worsened with a CPO of 0.4 W and a
PAPI of 0.3. We treated the patient for RV failure with a RV MCS
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device (Impella RP) (Figure 2). The patient was transferred to the cardiac intensive care unit (CICU) where hemodynamics and end organ

Cardiogenic shock (CS) affects 5–10% of patients who present with

perfusion continued to improve. Immediate revascularization was del-

acute myocardial infarction (AMI) and mortality remains greater than

ayed due to the patient's late presentation and to allow for multi-

40%.2 Early identification of CS is crucial for optimizing treatment in

disciplinary discussion for consideration of coronary artery bypass

an effort to improve mortality in this critically ill patient population.

grafting and mitral valve repair. Per recommendation of the Heart

Use of PCI, PACs, and early utilization of MCS devices are often

Team she underwent multivessel percutaneous coronary intervention

required.3,4 RV dysfunction occurs in approximately 40% of patients

(PCI) and subsequent weaning of MCS on day 3 of her hospitalization.

presenting with predominant LV shock and is associated with poorer

MCS was removed on day 4 and the patient was slowly weaned from

outcomes when compared with isolated univentricular shock.5 Clini-

dobutamine 5 mcg/kg/hr over the next few days. Repeat echocardio-

cians who do not routinely utilize PAC may fail to recognize RV dys-

gram on day 10 revealed an ejection fraction of 40%. Unfortunately,

function or failure; and this may significantly impact patient care. Our
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serial hemodynamic measures had not been obtained, immediate measures such as blood pressure may have reassured many clinicians
post-LV-MCS leading them to transfer the patient back to the cardiac
ICU where hemodynamic deterioration would have occurred.
Early identification of RV dysfunction plays an important role in
AMI-CS management. This is especially true after LV MCS placement,
when the strained RV will receive an increased flow that could culminate into RV failure. It is thus critical to have a high suspicion of RV
failure and consider serial hemodynamic monitoring. This can understandably be challenging in a busy cardiology center or in the late
hours of the night; however, it is important to note that these decisions and steps can greatly alter patient management. Invasive hemodynamic assessment of RV function is the fastest and most reliable
way to diagnose RV failure, with echocardiography providing additional benefit.9 It is important to mention that echocardiography alone
in the acute setting, may not reflect the acute changes to RV hemodynamics that can occur when using MCS.
Lastly, percutaneous right ventricular assist devices (RVAD)
include the Impella RP, Tandem Heart/Protek Duo, and extracorporeal
membrane oxygenation. There is no data to support the superiority of
F I G U R E 2 Fluoroscopy demonstrating an Impella CP, Impella RP,
and a Swan-ganz catheter

a specific RVAD and a multidisciplinary approach emphasizing operator and institutional expertise should be paramount.

case highlights the need for PACs and understanding invasive hemodynamic measures.

4
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Invasive hemodynamic are important in understanding the complex changes that occur when utilizing MCS devices. Early identifica-

Patients presenting with cardiogenic shock treated with MCS undergo

tion of RV failure is one such example.6,7 The use of invasive

significant and rapid hemodynamic changes that require the use of

hemodynamic parameters, such as CPO, PAPI, CVP/PCWP, and

pulmonary artery catheters to guide patient management. With

RVSWI, can help in the early diagnosis and management of RV failure.

greater utilization of MCS devices, it is imperative for clinicians to

In our case, knowing the patient had RV dysfunction was a warning to

understand the importance of these measures and their clinical utility.

closely monitor RV hemodynamics after placement of LV MCS. It is

We highlight an example of unmasking right ventricular failure after

important to note that the most common cause of RV dysfunction is

placement of left ventricular MCS through serial hemodynamic mea-

LV failure. The majority of patients with RV dysfunction, however, will

sures in the cardiac catheterization laboratory.

do well with LV unloading, diuresis, inotropes and supportive measures without the need for RV MCS. Hence in our case we elected to
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As shock management slowly diffuses away from surgeons to
advanced heart failure and interventional cardiologists, it is important

DATA AVAILABILITY STAT EMEN T

for our community to understand the importance of PACs and inva-
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and must become routine vocabulary. A CPO less than 0.6 W, for
example, suggests significant ventricular dysfunction and poor forward flow, while a PAPI of less than 1.0 is suggestive of RVF in AMICS.8 Additional hemodynamic parameters such as CVP/PCWP greater
than 0.8, a CVP greater than 12–15 mmHg and a right ventricular
stroke work index (RVSWI) less than 300 g m/m2 are all important
measures interventional cardiologists should be familiar with when
caring for shock patients.8 In our patient, all of the above measures
confirmed the presence of RVF. If a PAC had not been placed and
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